Local therapy of intestinal fistulas with autogenous mesenchymal cells in patients with refractory Crohn's disease

References

[1] Burt R.K., Traynor A., Oyama Y., Craig R. High-dose immune suppression and autologous hematopoietic stem cell transplantation in refractory Crohn disease. Blood 2003; 101; 5: 2064-6.

[2] Oyama., Craig R.M., Traynor A.E. at al. Autologous hematopoietic stem cell transplantation in patients with refractory Crohn's disease. Gastroenterol. 2005; 128: 552-63.

[3] Lopez-Cubero S.O., Sullivan K.M., McDonald G.B. Course of Crohn's disease after allogeneic marrow transplantation. Gastroenterol. 1998;114: 433-0.

[4] Kreisel W., Potthoff K., Bertz H. et al. Complete remission of Crohn's disease after high-dose cyclophosphamide and autologous stem cell transplantation. Bone Marrow Transplant. 2003; 32; 3: 337-40.

[5] Hess D, Li L., Martin M. et al. Bone marrow-derived stem cells initiate pancreatic regeneration. Nat. Biotechbol. 2003; 21 ; 7: 763-70.

[6] Yannaki E., Athanasiou E., Xagorari A. et al. G-CSF-primed hematopoietic stem cells or G-CSF per se accelerate recovery and improve survival after liver injury, predominantly by promoting endogenous repair programs. Exp. Hematol. 2005; 33: 108-19.

[7] Garcia-Olmo D., Garcia-Arranz M., Garcia L.G. et al. Autologous stem cell transplantation for treatment of rectovaginal fistula in perianal Crohn's disease: a new cell-based therapy. Int. J. Colorectal Dis. 2003; 18: 451 -4.

[8] Houghton J.-M., Stoicov C., Sachiyo Nomura, et al. Gastric cancer originating from bone marrow-derived cells. Science 2004; 306: 1568-71.

[9] Rius, J., Nessim A, Nogueras J.J., Wexner S.D. Gracilis transposition in complicated perianal fistula and unhealed perineal wounds in Crohn's disease. Eur. J. Surg. 2000; 166: 218-22.

[10] Mizuno H., Zuk P.A., Zhu M. et al. Myogenic differentiation by human processed lipoaspirate cells. Plast. Reconstr. Surg. 2002; 109: 199-09.

RIGHTS & PERMISSIONS

Eco-Vector